RBGEX | RGWEX | RBGEX / RGWEX | |
Total Expense Ratio | 1.17 | 0.71 | 165% |
Annual Report Gross Expense Ratio | 1.17 | 0.71 | 165% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 15.806 | 16.246 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.2B | 24.2B | 100% |
Annual Yield % from dividends | 0.00 | 0.41 | - |
Returns for 1 year | 10.76 | 11.41 | 94% |
Returns for 3 years | 60.24 | 62.43 | 96% |
Returns for 5 years | 43.70 | 46.62 | 94% |
Returns for 10 years | 104.30 | 111.05 | 94% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 91.08 | 0.87 | +0.96% |
Invesco Pharmaceuticals ETF | |||
FFEB | 54.93 | 0.17 | +0.32% |
FT Vest US Equity Buffer ETF Feb | |||
NUAG | 21.27 | 0.02 | +0.12% |
Nuveen Enhanced Yield US Aggt Bd ETF | |||
KPDD | 25.72 | -0.47 | -1.79% |
KraneShares 2x Long PDD Daily ETF | |||
RXD | 11.91 | -0.24 | -2.00% |
ProShares UltraShort Health Care |